Interventional Radiological Treatment of Hepatocellular Carcinoma: An Update

Indian Journal of Surgery

Volumn 74, Issue 1, 2012, Pages 91-99

  Shrimal, Anurag ^a   Prasanth, Madhu ^a   Kulkarni, A V ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

HCC; Interventional radiological treatments; Radioembolization; Radiofrequency ablation; TACE

Indexed keywords

EID: 84855978242     PISSN: 09722068     EISSN: 09739793     Source Type: Journal    
DOI: 10.1007/s12262-011-0377-4     Document Type: Article

References (59)

1. El-Serag HB, Mason AC, Key C (2009) Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Heptology 33(1): 62-65.
2. Altekruse SF, McGylnn KA, Reichman ME (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27(9): 1485-1491.
3. Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I et al (2005) Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for Hepatocellular carcinoma. Liver Transpl 11(9): 1086-1092.
4. Otto G, Heuschen U, Hofmann WJ, Krumm G, Hinz U, Herfarth C (1998) Survival and recurrence after liver transplantation versus liver resection for Hepatocellular carcinoma: a retrospective analysis. Ann Surg 227(3): 424-432.
5. Poon RT, Fan ST, Lo CM, Liu CL, Wong J (2002) Long term survival and pattern of recurrence after resection of small Hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235(3): 373-382.
6. Dodd GD 3rd, Soulen MC, Kane RA, Livraghi T, Lees WR, Yamashita Y et al (2000) Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 20: 9-27.
7. Sakamoto I, Aso N, Nagaoki K, Matsuoka Y, Uetani M, Ashizawa K et al (1998) Complications associated with transcatheter arterial embolization for hepatic tumors. Radiographics 18(3): 605-619.
8. Kan Z, McCuskey PA, Wright KC, Wallace S (1994) Role of Kupffer cells in iodized oil embolization. Invest Radiol 29(11): 990-993.
9. Konno T (1990) Targeting cancer chemotherapeutic agents by the use of lipiodol contrast medium. Cancer 29(11): 990-993.
10. Sasaki Y, Imoka S, Kasugai H, Fujita M, Kawamoto S, Ishiguro S et al (1987) A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer 60(6): 1194-1203.
11. Varela M, Real MI, Burrel FA, Sala M, Brunet M et al (2007) Chemoembolization of Hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46(3): 474-481.
12. Olweny CL, Katongole-Mbidde E, Mugerwa J, Kyalwazi SK, Cohen H (1975) Treatment of hepatocellular carcinoma with adriamycin. Preliminary communication. Cancer 36(4): 1250-1257.
13. Olweny CL, Kantongole-Mbidde E, Bahendeka S, Otim D, Mugerwa J, Kyalwazi SK (1980) Further experience in treating patients with hepatocellular carcinoma in Uganda. Cancer 46(12): 2717-2722.
14. Lai CL, Wu PC, Chan GC et al (1988) Doxorubicin versus no antitumor therapy in inoperable Hepatocellular carcinoma. A prospective randomized trial. Cancer 62(3): 479-483.
15. Ramsey DE, Kernagis LY, Soulen MC, Geschwind JF (2002) Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 13(9 Pt 2): S211-S221.
16. Liapi E, Geogiades CC, Hong K, Geschwind JF (2007) Transcatheter arterial chemoembolization: current technique and future promise. Tech Vasc Interv Radiol 10(1): 2-11.
17. Liu DM, Salem R, Bui JT et al (2005) Angiographic and technical considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16(7): 911-935.
18. Virmani S, Ryu RK, Sato KT, Lewandowski RJ, Kulik L, Mulcahy MF (2007) Effect of C-arm angiographic CT on transcatheter arterial chemoembolization of liver tumors. J Vasc Interv Radiol 18(10): 1305-1309.
19. Wallace MJ, Murthy R, Kamat PP, Moore T, Rao SH, Ensor J et al (2007) Impact of C-arm CT on hepatic arterial interventions for hepatic malignancies. J Vasc Interv Radiol 18(12): 1500-1507.
20. Convey AM, Brody LA, Maluccio MA, Getrajdman GI, Brown KT (2002) Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. Radiology 224(2): 542-547.
21. Song SY, Chung JW, Lim HG, Park JH (2006) Nonhepatic arteries originating from hepatic arteries: angiographic analysis in 250 patients. J Vasc Interv Radiol 17(3): 461-469.
22. Brown DB, Cardella JF, Sacks D, Goldberg SN, Gervais DA, Rajan DK et al (2009) Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 20(Suppl 7): S219-S226, e1-e10.
23. Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T et al (2006) Prospective cohort study of transarterial chemoembolization for unresectable Hepatocellular carcinoma in 8510 patients. Gastroenterology 131(2): 461-469.
24. Brown DB, Geschwind JF, Soulen MC, Millward SF, Sacks D (2009) Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies. J Vasc Interv Radiol 20(Suppl 7): S317-S323.
25. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J et al (2002) Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359(9319): 1734-1739.
26. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT et al (2002) Randomized controlled trial of Transarterial lipiodol chemoembolization for unresectable Hepatocellular carcinoma. Hepatology 35(5): 1164-1171.
27. Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable Hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37(2): 429-442.
28. Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F et al (2002) Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 224(1): 47-54.
29. Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A et al (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33(1): 41-52.
30. Malagari K, Pomoni M, Kelekis A, Pomoni A, Dourakis S, Spyridopoulos T et al (2010) Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma. Cardiovasc Intervent Radiol 33(3): 541-551.
31. Salem R, Lewandowski R, Roberts C, Goin J, Thurston K, Abouljoud M et al (2004) Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma with portal vein thrombosis. J Vasc Interv Radiol 15(4): 335-345.
32. Riaz A, Lewandowski R, Kulik L (2009) Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. J Vasc Interv Radiol 20(9): 1121-1130.
33. Salem R, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Ibrahim S et al (2010) Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology 138(1): 52-64.
34. Kooby DA, Egnatashivili V, Srinivasan S, Chamsuddin A, Delman KA, Kauh J et al (2010) Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 21(2): 224-230.
35. Ishii H, Okada S, Nose H, Okusaka T, Yoshimori M, Takayama T et al (1996) Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 77(9): 1792-1976.
36. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L et al (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 228(1): 235-240.
37. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T et al (2005) A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129(1): 122-130.
38. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC (2005) Randomized controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54(8): 1151-1156.
39. Orlando A, Leandro G, Olivo M, Andriulli A, Cottone M (2009) Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol 104(2): 514-524.
40. Crocetti L, de Baere T, Lencioni R (2010) Quality improvement guidelines for radiofrequency ablation of liver tumors. Cardiovasc Intervent Radiol 33: 11-17.
41. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN (2003) Treatment of focal liver tumors with percutaneous radiofrequency ablation: complications encountered in a multicenter study. Radiology 226: 441-451.
42. Latteri F, Sandonato L, Di Marco V, Parisi P, Cabibbo G, Lombardo G et al (2008) Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study. Dig Liver Dis 40: 684-689.
43. Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G et al (2002) Complications of radiofrequency coagulation of liver tumors. Br J Surg 89: 1206-1222.
44. Lu DS, Raman SS, Limanond P, Aziz D, Economou J, Busuttil R et al (2003) Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 14(10): 1267-1274.
45. Chang I, Mikityansky I, Wary-Cahen D, Pritchard WF, Karanian JW, Wood BJ (2004) Effects of perfusion on radiofrequency ablation in swine kidneys. Radiology 231(2): 500-505.
46. Pompili M, Mirante VG, Rondinara G, Fassati LR, Piscaglia F, Agnes S et al (2005) Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl 11(9): 1117-1126.
47. Choi H, Evelyne M, Charnsangavej C (2007) Radiographic imaging following radiofrequency ablation of liver tumors. In: Ellis LM, Curley SA, Tanabe KK (eds) Radiofrequency ablation for cancer: current indications, techniques, and outcomes. Springer, New York, pp 253-267.
48. Lim HK, Choi D, Lee WJ, Kim SH, Lee SJ, Jang HJ et al (2001) Hepatocellular carcinoma treated with percutaneous radiofrequency ablation: evaluation with follow-up multiphase helical CT. Radiology 221: 447-454.
49. Goldberg SN, Gazelle GS, Solbiati L, Livraghi T, Tanabe KK, Hahn PF et al (1998) Ablation of liver tumors using percutaneous RF therapy. AJR Am J Roentgenol 170: 1023-1028.
50. McGhana JP, Dodd GD 3rd (2001) Radiofrequency ablation of liver: current status. AJR Am J Roentgenol 176: 3-16.
51. deBaere T, Risse O, Kuonch V, Dromain C, Sengel C, Smayra T et al (2003) Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 181: 695-700.
52. Kim YS, Rhim H, Lim HK (2009) Imaging after radiofrequency ablation of hepatic tumor. Semin Ultrasound CT MR 30: 49-66.
53. Choi D, Lim HK, Kim MJ, Kim SJ, Kim SH, Lee WJ et al (2005) Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factors. AJR Am J Roentgenol 184: 1860-1867.
54. Akahane M, Koga H, Kato N, Yamada H, Uozumi K, Tateishi R et al (2005) Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management. Radiographics 25(Suppl 1): S57-S68.
55. Tamai F, Furuse J, Maru Y, Yoshino M (2002) Intrahepatic pseudoaneurysm: a complication following radiofrequency ablation therapy for hepatocellular carcinoma. Eur J Radiol 44: 40-43.
56. Kim YS, Rhim H, Lim HK, Choi D, Lee WJ, Kim SH (2007) Hepatic infarction after radiofrequency ablation of hepatocellular carcinoma with internally cooled electrode. J Vasc Interv Radiol 18: 1126-1133.
57. Kim MD, Kim H, Kang SW, Jeong BG (2002) Nontraumatic hepatic artery pseudoaneurysm associated with acute leukemia: a possible complication of pyogenic liver abscess. Abdom Imaging 27: 458-460.
58. Jaskolka JD, Asch MR, Kachura JR, Ho CS, Ossip M, Wong F et al (2005) Needle tract seeding after radiofrequency ablation of hepatic tumors. J Vasc Interv Radiol 16(4): 485-491.
59. Sung GT, Gill IS, Hsu TH, Meraney AM, Skacel M, Brainard JA et al (2003) Effect of intentional cryo-injury to the renal collecting system. J Urol 170(2 Pt 1): 619-622.